全球知识产权每日洞察 — 2026-07-16

Context:

Claims (and counterclaims) over fair, reasonable, and non-discriminatory (FRAND) licenses to standard-essential patents (SEPs) are a common feature of bilateral licensing disputes. However, there are systemic implications for the standards ecosystem when courts consider extending the concept of judicial rate-setting (with or without compulsory licenses involved) to patent pools. The UK Supreme Court (UKSC) is presently working on its

Tesla v. InterDigital & Avanci

decision (

April 27, 2026

Context:

Illumina is the dominant player in next-generation DNA sequencing, commanding an estimated 80% to 90% share of the global market for short-read sequencing instruments and consumables. Element Biosciences is a San Diego-based sequencing startup founded in 2017 by three former Illumina employees, offering a lower-cost rival platform built on its own “avidity” chemistry. Illumina sued Element in the District of Delaware in May 2025 over five patents related to automated gene sequencing (

May 16, 2025

ip fray

article

Context

: Dolby and Access Advance have been pursuing a global licensing campaign against Snap over the alleged use of High Efficiency Video Coding (HEVC) technology in Snapchat’s backend video processing. The dispute already spans the United States and Brazil (

June 10, 2026

ip fray

article

Context:

Moderna, Pfizer, and Sanofi each began development of Covid-19 vaccines based on messenger ribonucleic acid (mRNA) technology in the wake of the global pandemic which broke out in late 2019. Moderna and Pfizer rapidly emerged as leaders, while Sanofi effectively abandoned its effort.

To Read The Full Story

Sign In

Continue reading your article with a Membership